Revenue from operations declined to Rs 593 crore in the quarter from Rs 749 crore in the year-ago period. The drug firm said exceptional items for June quarter comprised Rs 130 crore on account of a voluntary retirement scheme and Rs 6 crore for re. .

.

Comments
  • No comment posted so far for this feed.
    Be the first one to post.
Please login to post comment!